Home » Topics » BioWorld Science

BioWorld Science
RSS

Discovery may allow more selective chemokine targeting

April 6, 2022

Targinta selects TARG-9 as drug candidate

April 6, 2022

VBI Vaccines reports new preclinical data from coronavirus program VBI-2900

April 6, 2022

BMP-9 is required for survival after acute myocardial infarction

April 6, 2022

P-selectin associated with COVID-19 severity and mortality

April 6, 2022

Gut reaction to rapamycin extends female fly lifespan

April 5, 2022

TEM1 is a marker of heart failure severity

April 5, 2022

Plasma desmosine is a prognostic factor in acute myocardial infarction

April 5, 2022

CARB-X option funding supports Clarametyx's development of anti-biofilm therapy CMTX-101

April 5, 2022

Aligos selects broad-spectrum coronavirus protease inhibitor ALG-097558 for advancement

April 5, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 31, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026